Navigation Links
Key to Hepatitis C May Be Two Cellular Proteins
Date:1/8/2010

Finding could lead to treatment with the natural compound Quercetin

FRIDAY, Jan. 8 (HealthDay News) -- Researchers have identified two cellular proteins that play an important role in hepatitis C infection, and they say the finding may point to new and less toxic treatments for the disease, which can lead to cirrhosis and liver cancer.

The conventional treatments for hepatitis C are interferon and ribavirin, which can cause major side effects and aren't effective in all patients. A new drug that targets cellular proteins rather than viral proteins would be an important advance in treatment, according to the team from the University of California at Los Angeles.

The researchers found that heat shock proteins 40 and 70 are major cellular factors in hepatitis C infection. They also discovered that a natural compound called Quercetin blocks the synthesis of these proteins and significantly inhibited viral infection in tissue culture.

Quercetin -- a plant-based bioflavonoid sometimes used as a nutritional supplement -- may have anti-inflammatory and antioxidant properties.

"This is an important finding because we can block these proteins with the idea of reducing the level of the virus in people and, ideally, completely eliminate it," study senior author Samuel French, an assistant professor of pathology, said in a UCLA news release.

The study was published in the December issue of the journal Hepatology.

A phase 1 clinical trial will be conducted at UCLA to determine if Quercetin is safe and effective in patients with type 1 hepatitis C. Only about 50 percent of patients with type 1 hepatitis C respond to treatment.

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.



-- Robert Preidt



SOURCE: University of California at Los Angeles, news release, Jan. 4, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hepatitis B Foundation awards UT School of Public Health professor
2. NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus
3. New Hepatitis C Treatment Shows Promise
4. NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is Wake-Up Call for Washington
5. Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
6. Lloyd Wright's Alternative Medicine Has One of its Hepatitis C Viral Inhibitors Given Boost as Scripps Study Peptides Effectiveness
7. NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on Viral Hepatitis Detection, Management Funding
8. Lloyd Wright's Alternative Medicine Marketing Only Blueberry Extract with 45% of Hepatitis C Inhibitor Proanthocyanidin
9. African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C
10. Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
11. Hepatitis B does not increase risk for pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading provider of ... with WALLIX to expand its solution to help government contractors more quickly ... number of ways to address the authentication requirements within NIST SP800-171, but no ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... fat (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 ... its adipose filtration technology. The '398 and '324 patents cover methods and ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... solution focused on delivering end-to-end sleep health care at scale, indicates record-breaking ... shows that adherence rates for positive airway pressure (PAP) therapy, the most widely ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating clubfoot as ... 100,000 children in their treatment program. Clubfoot is a pervasive problem in the ... is limited or non-existent. Without intervention, these children are destined to grow up ...
(Date:7/24/2017)... ... 24, 2017 , ... On July 19th, the Chinese Academy ... the awarding ceremony was held successfully in Beijing. The State Health Planning Commission, ... system, and national Chinese medicine experts also attended the event, including more than ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
(Date:7/12/2017)...  Eli Lilly and Company (NYSE: LLY ) ... resolve pending patent litigation in the U.S. District Court for ... the Cialis ® (tadalafil) unit dose patent. This patent ... part of the agreement, Cialis exclusivity is now expected to ... "The unit dose patent for Cialis is valid and infringed ...
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
Breaking Medicine Technology: